BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes GlobeNewswire January 07, 2026 Decision ensures continued patient access to VENDAJE(R) and VENDAJE AC(R) POMPANO BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization […]

Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026 Planned milestones include pivotal dose selection, EOP2 regulatory interaction in mid-2026, updated and expanded CARDINAL data by 2H26, and initiation

Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE(R) Advanced Surgical Solution GlobeNewswire January 07, 2026 Contract awarded for products that bring improvement to the healthcare industry FORT WORTH, TX, Jan. 07, 2026 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara MedTech,” “Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology

Terrestrial Energy to Participate in the 28th Annual Needham Growth Conference GlobeNewswire January 07, 2026 CHARLOTTE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) — Terrestrial Energy Inc. (NASDAQ: IMSR) (“Terrestrial Energy” or “the Company”), a developer of small modular nuclear power plants using its Generation IV reactor technology, announced today that it will participate in the

Twelve Seas Investment Company III Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 9, 2026 GlobeNewswire January 07, 2026 New York, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) — Twelve Seas Investment Company III (Nasdaq: TWLVU) (the “Company“) announced today that, commencing January 9, 2026, holders of the units sold

Constellation Brands Reports Third Quarter Fiscal 2026 Financial Results GlobeNewswire January 07, 2026 ROCHESTER, N.Y., Jan. 07, 2026 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its third quarter fiscal 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President

Bitfarms to Present at Needham Growth Conference in NYC GlobeNewswire January 07, 2026 TORONTO, Ontario and NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ/TSX: BITF), a North American energy and digital infrastructure company, will participate in Needham's 28th Annual Growth Conference, taking place from January 13-14 in New York City. A management

RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that

iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation GlobeNewswire January 07, 2026 NASHVILLE, Tenn., Jan. 07, 2026 (GLOBE NEWSWIRE) — Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced members of its management team will participate in the following investor conferences this winter, which will include hosting meetings around the annual J.P. Morgan

Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 NOVATO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D.,